Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas.

Blood Adv · 2025 · PMC11995064 · PMID 39908567

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

reached borderline significanceno p-value reported

After adjusting for multiple testing using the Benjamini and Hochberg FDR, 25 IgG Abs at the 3-month postinfusion time point reached borderline significance (FDR = 0.058).

also in 93 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.